E Fund Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Sell |
|
|||||
|
2025
Q1 | $1.02M | Buy |
|
|||||
|
2024
Q4 | $1.02M | Sell |
|
|||||
|
2024
Q3 | $1.02M | Buy |
|
|||||
|
2024
Q2 | $1.01M | Buy |
|
|||||
|
2024
Q1 | $429K | Sell |
|
|||||
|
2023
Q4 | $540K | Sell |
|
|||||
|
2023
Q3 | $471K | Sell |
|
|||||
|
2023
Q2 | $451K | Buy |
|
|||||
|
2023
Q1 | $408K | Buy |
|
|||||
|
2022
Q4 | $431K | Sell |
|
|||||
|
2022
Q3 | $475K | Sell |
|
|||||
|
2022
Q2 | $453K | Buy |
|
|||||
|
2022
Q1 | $282K | Buy |
|